Ligand Pharmaceuticals logo

Ligand Pharmaceuticals

Investments
4
Lead Investments
2

Ligand is a biopharmaceutical company focused on developing or acquiring technologies that help pharmaceutical companies discover and develop medicines. Ligand business model creates value for stockholders by providing a diversified portfolio of biotech and pharmaceutical product revenue streams that are supported by an efficient and low corporate cost structure. Ligand's goal is to offer investors an opportunity to participate in the promise of the biotech industry in a profitable, diversified, and lower-risk business than a typical biotech company. Ligand business model is based on doing what we do best: drug discovery, early-stage drug development, product reformulation, and partnering. Ligand partner with other pharmaceutical companies to leverage what they do best (late-stage development, regulatory management, and commercialization) to ultimately generate Ligand revenue.

Founded 1987
North America, United States
51-100
ligand.com

Highlights

Focus Areas

Biotechnology
Health Care
Therapeutics
Life Science
Medical Device

Investment Types

Early Stage Venture
Late Stage Venture

Notable Investments

Orchestra BioMed logo
Palvella Therapeutics logo
Dianomi Therapeutics logo

Investment History

Team